Pay in 4 interest-free payments of $5.05 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
Key Differences Summary# Molecular design : Amycretin is a single molecule activating two receptors
Dapagliflozin versus glipizide as add-on therapy in patients with type 2 diabetes who have inadequate glycemic control with metformin: a randomized, 52-week, double-blind, active-controlled noninferiority trial
Presented for research literature review only Young PR et al
Broad Institute Connectivity Map analysis shows it influences approximately 6% of the human genome making this one of the most broadly active signaling peptides in published research
10.1186/s12905-022-02056-7 242 WuH.LiuQ.YangN.XuS
US$ 21.37
US$ 28.35
US$ 25.26
